Variable | Palliative chemotherapy | BSC | Â | OR (95%CI) | P-value |
---|---|---|---|---|---|
101 (78.3%) | 28(21.7%) | 129 | Â | Â | |
Type of cancer | |||||
 Gastric ca. | 46 (83.6%) | 9 (16.4%) | 55 | 18.88 (1.59–224.59) | < 0.05* |
 Colon ca. | 32 (86.5%) | 5 (13.5%) | 37 | 21.99 (1.74–277.45) | < 0.05* |
 Esophageal ca. | 13 (76.5%) | 4 (23.5%) | 17 | 13.55 (0.95–192.92) | 0.054 |
 MMT | 9 (69.2%) | 4 (30.8%) | 13 | 5.83 (0.41–83.02) | 0.193 |
 CUP | 1 (14.3%) | 6 (85.7%) | 7 | 1.00 (ref.) |  |
Sex | |||||
 Female | 28 (73.7%) | 10 (26.3%) | 38 | 0.53 (0.18–1.53) | 0.237 |
 Male | 73 (80.2%) | 18 (19.8%) | 91 | 1.00 (ref.) |  |
Age(years) | |||||
  ≤ 70 | 62 (84.9%) | 11 (15.1%) | 73 | 3.32 (1.16–9.54) | < 0.05* |
  > 70 | 39 (69.6%) | 17 (30.4%) | 56 | 1.00 (ref.) |  |
ECOG PS | |||||
 0–2 | 91 (84.3%) | 17 (15.7%) | 108 | 4.99 (1.52–16.42) | < 0.01* |
 3–4 | 10 (47.6%) | 11 (52.4%) | 21 | 1.00 (ref.) |  |